Aclarion Raises $10.4M, Extends Runway to 2028 and Accelerates CLARITY Enrollment
Aclarion closed a $10.4M equity financing at $5.18 per share, boosting cash reserves to $21.6M with zero debt and extending its runway into 2028. The company plans to accelerate CLARITY trial enrollment to 25% by Q2 2026, expand MRI platform reach by over 30%, and pursue broader payer reimbursement.
Related News
GROW
US Global Investors Sees 15% AUM Gain, 31% Revenue Growth and $2.6M Profit
GROW•
META
Manus Founders Seek $1B Raise to Unwind Meta's $2B AI Acquisition
META•
AMZN
AWS Faces Challenge as Nvidia Forecasts $91B Q3 Sales, Musk Eyes 2028 Space Data Centers
AMZN•
INTU
Intuit to Launch AI-Driven Platforms in August, Cuts 17% Workforce to Fund Growth
INTU•
NEWP
Bolivia Overhauls Regulations as New Pacific Metals Poised for $700 Million Mining Boost
NEWP•
Sources
BG